Baseline Characteristics and Treatment Response to Ixekizumab Categorised by Sex in Radiographic and Non-radiographic Axial Spondylarthritis Through 52 Weeks: Data from Three Phase III Randomised Controlled Trials

OBJECTIVES: Assess baseline characteristics and treatment response to ixekizumab (IXE) categorised by sex in patients with radiographic axial spondyloarthritis (r-axSpA) and non-radiographic axSpA (nr-axSpA) up to 52 weeks. METHODS: Data were analysed from three randomised controlled trials of IXE t...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Horst-Bruinsma, Irene E., de Vlam, Kurt, Walsh, Jessica A., Bolce, Rebecca, Hunter, Theresa, Sandoval, David, Zhu, Danting, Geneus, Vladimir, Soriano, Enrique R., Magrey, Marina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9123018/
https://www.ncbi.nlm.nih.gov/pubmed/35429281
http://dx.doi.org/10.1007/s12325-022-02132-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9123018/
https://www.ncbi.nlm.nih.gov/pubmed/35429281
http://dx.doi.org/10.1007/s12325-022-02132-2

Ejemplares similares